IntelGenx Q2 2023: Revenue Decline 67%, Operating Costs Rise

IntelGenx Technologies Corp. (TSX: IGX) (OTC: IGXT), a drug delivery company focused on the development and manufacturing of pharmaceutical films, reported its financial results on Monday for the second quarter ending on June 30, 2023.

Related Keywords

Montelukast Versafilm , Dwight Gorham , Intelgenx Technologies Corp , Ma Health , Revenue Dip , Strategic Successes , Health Canada Approved , Comprehensive Loss ,